SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0000950135-05-004212
Filing Date
2005-07-28
Accepted
2005-07-28 06:08:13
Documents
1
Effectiveness Date
2005-07-28

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC. b56074tte15v12g.htm 15-12G 8732
  Complete submission text file 0000950135-05-004212.txt   10031
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 000-21481 | Film No.: 05978948
SIC: 2836 Biological Products, (No Diagnostic Substances)